celltrionhealthcare 091990 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 091990 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2018.06 2018.09 2018.12 2019.03 2019.06 2019.09
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 7,333 9,209 7,135 7,892 1,838 2,127 1,887 2,205 2,365 2,952 2,014
O-profit 1,553 1,537 -252 946 152 200 -689 94 85 302 -61
N-income 972 1,574 114 887 110 64 -665 58 60 134 -108
O-rate 21.2 16.7 -3.5 11.4 8.3 9.4 -36.5 4.3 3.6 10.2 -3.6
N-rate 13.3 17.1 1.6 10.6 6.0 3.0 -35.2 2.6 2.5 4.6 -5.9
ROE 17.7 9.2 0.7 9.2 2.5 1.9 -4.0 0.5 0.5 0.8 0.2
Debt-ratio 264.5 68.4 80.3 137.7 61.1 66.9 80.3 77.0 85.0 93.7 71.3
Quick-ratio 37.9 123.2 82.4 81.2 98.8 94.6 82.4 81.4 113.0 192.9 89.3
reserve-ratio 435.2 1,183.1 1,170.5 929.6 1,217.2 1,221.9 1,170.5 1,149.7 1,130.6 1,112.3 1,189.8
EPS 676 1,094 79 617 76 45 -462 40 43 57 -75
BPS 3,826 11,873 11,372 9,024 12,439 12,426 11,372 11,267 10,797 10,347 11,876
Dividends 0 0 0 0
2019-07-05
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 53 %
High mid ~ 32 %
Mid ~ 11 %
Low mid ~ -9 %
Low price ~ -30 %
Indication price Range Current stock price Company score
75,044 W 75,044 W 63,184 W
63,184 W 63,184 W 51,324 W Evaluation
86,904 W 86,904 W~ 75,044 W
56,700 W
42.251,324 W 51,324 W 39,465 W
Mid
Normal
39,465 W 39,465 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 81 40 3,009 1,494
39,465원
51,324원
63,184원
75,044원
86,904원
Mid 56,700원
-30%
-9%
11.4%
32.4%
53.3%
-40%
-30%
-20%
-10%
0.%
10.%
20.%
30.%
40.%
50.%
60.%
0W
10,000W
20,000W
30,000W
40,000W
50,000W
60,000W
70,000W
80,000W
90,000W
100,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
celltrionhealthcare
Gap
celltrionhealthcare

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 091990 Date
Period
Gap
(Indication /
stock)
Color
2019-07-05
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
56,700 W Mid 44.2 Normal 2,000,000 W
Suggested Purchase
Amount 661,416 W
Number of stocks
purchased 12
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 86,904 W 86,904 W~ ~ 75,044 W 53 % -352,336 W -4
High mid 75,044 W 75,044 W ~ 63,184 W 32 % -213,988 W -3
Mid 63,184 W 63,184 W ~ 51,324 W 11 % -75,641 W -1
Low mid 51,324 W 51,324 W ~ 39,465 W -9 % 62,707 W 1
low price 39,465 W 39,465 W ~ 0 W -30 % 201,054 W 5
Stock price rise
probability score
A Sector 44.6 48.1 46.1 45.3 48.8 49.3
44.2B Sector 35.0 42.1 35.4 45.3 32.9 13.8
Total average
2019.02.08 2019.03.11 2019.04.08 2019.05.08 2019.06.05 2019.07.04
39.8 45.1 40.7 30.8 40.8 31.5
25 % -30 %
2019.03.11 2019.04.08 2019.05.08 2019.06.05 2019.07.04
Total of
increase rate
Total score
A Sector 7 % -4 % -2 % 7 % 1 %
-7 % 42.0B Sector 17 % -19 % 22 % -38 % -139 %
Total average 12 % -11 % -32 %
45
48 46 45
49 49
35
42
35
45
33
14
40
45
41
31
41
32
0
10
20
30
40
50
60
2019.02.08 2019.03.11 2019.04.08 2019.05.08 2019.06.05 2019.07.04
Stock price rise probability score
A sector
B sector
Total average
7%
-4% -2%
7% 1%
17%
-19%
22%
-38%
-139%
12%
-11%
-32%
25%
-30%
-150%
-100%
-50%
0%
50%
2019.03.11 2019.04.08 2019.05.08 2019.06.05 2019.07.04
Increase rate of stock price rise
A sector
B sector
Total average
celltrionhealthcare

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting
The Algori
accuracy o
change ove
results of
Consulting
②
informatio
investmen
up
③
do anythin
transaction
④
The Algori
informatio
⑤
analysis re